Define the programme before comparing options
Equipment is one part of a manufacturing programme. The institution also needs to examine people, workflows, quality systems, supply arrangements and regulatory responsibilities. A comparison is useful only when both options are evaluated for the same intended use and institutional baseline.
No validated vendor comparison, comparative cost or operational outcome has been supplied for this website. The build-versus-buy page is a discussion scaffold for collecting that evidence, not a procurement recommendation.
Separate equipment scope from transfer scope
Request the equipment supplier’s installation footprint, utilities, biosafety and cleanroom requirements. Confirm the operator training, service support and validation responsibilities included in the purchase.
Compare that documented scope with the proposed technology-transfer deliverables. The supplied transfer list includes the following areas:
- SOP development
- Quality assurance framework
- Batch record templates
- Release testing protocols
- Staff training programmes
- Competency assessments
Seven decision areas to evidence
Use named sources for each option. Mark a missing quotation, assumption or contract term as unresolved instead of filling the gap with a performance claim.
- Facility: site assessment, utilities and supplier specifications.
- Staffing: local skills, training scope and ongoing support.
- Processes: workflows, validation, SOPs and batch records.
- Regulatory ownership: national pathway and local dossier responsibilities.
- Vector supply and IP: access, continuity, permitted use and licensing terms.
- Cost: dated quotations and comparable recurring-cost assumptions.
- Operational sustainability: maintenance, governance and long-term continuity.
Use a comparable cost boundary
A purchase price and a programme price may cover different things. Request a consistent boundary for equipment, consumables, utilities, staffing, maintenance, training and recurring supply. Document what is included, excluded and assumed in each estimate.
Comparable, dated total-cost estimates have not been supplied. The feasibility process is where input costs, resource needs and investment requirements are assessed before a final quotation.
Take the evidence into feasibility
Disease burden analysis, regulatory landscape review, infrastructure audit and commercial feasibility before any commitments are made.
A useful first discussion brings the proposed platform and intended use, the institutional baseline, the local regulatory pathway and the evidence still needed for a decision. Programme-specific scope and commercial commitments follow that assessment.
